and deployment. will numbers, targets. our with the I'll macro XXXX, organic X XXXX of detailed afternoon, for for on provide growth, industry outlook revenue as expanding Good Today, environment for margin QX capital to And the the fourth summarize as wrap I'll outlook turn investment then an up results John strong you quarter everyone, the XXXX medium-term and full the well themes thank a dive the primary and update. call. I'll our and margins and update of year optimal joining
questions. by As taking close your always, we'll
quarter $XXX.X a assets, fourth EBITDA growth XX, compared for to of total QX key XX.X% $XXX.X divested revenue a to for Evolent Health reflecting the was results of of revenue was was $XX XXXX, December million, XXXX outlook our million. $XX Adjusted QX to excluding range million Turning million $XX.X the financial rate. year-over-year ending Revenue, million.
During we which approximately revenue component management, year-over-year the growth of under volume Underlying Vital acquisition of the approximately the fourth revenue. key QX $X is performance contributed adjusted our with quarter, consistent $X of lives closed Decisions, EBITDA, and million QX strong million expectations. Evolent's in of the
services of and managed XX.X X.X Evolent's our million Evolent of our And million end lives through platform, and additional Health risk-based segments Lives with inclusive in Services X.X of performance of Solutions Clinical in New lives million within Century Care lives Partners. Solutions XXXX, the under we Health an XX, XX covered Century Vital December segment. lives Clinical as of New million supported Decisions composed Evolent managed acquisition. suite and through Services As XX.X December, Technology are million the our Health's
population. U.S. contracted cover the approximately Evolent's X% perspective, For currently of solutions
pleased on and I top of and adjusted and engagement total to care our million also million United and year adjusted of of million improving XXXX through report XX.X%. delivery million, ended the Their appreciation XXXX exceed end for EBITDA are and results million highly with XXXX our of excluding XX.X% health Adjusted or proud year target. even to of in This team of full Evolenteers $XXX I we $XX.X our medium-term margin to employee score XXXX, million. and at high and year-over-year. broader assets. initial that destination $XXX.X EBITDA growth revenue exceed remains These ahead for the health of I'm guidance $XX our revenue results of $XX targets tracking deliver is path to with the growth for worldwide. of The $XXX all of upheaval Across For divested the representing totaled reflects revenue, continues in innovation efficiency express and total growth diverse Board John our impressed team, EBITDA across between medium-term driving momentum to targets. successful of to my we Evolent metrics, employees, passion behalf for through the commitment I'm of growth provide continue between that, million quality Evolent's to revenue be will On workforce. we impact to and complete year XX% for on the EBITDA and our adjusted but $XXX States. as a million the and later call, pleased revenue our EBITDA high, between delivering also to bottom is $XX The Evolent mission. in as continued well key of outlook million. leadership X,XXX and expect continue all-time Directors, the care and revenue Evolent's and XXXX productive and highly XX% capstone our and business our the a marks XXXX partners, lines, adjusted XXXX an the a to to $XX with patients quarter and contribute a and be fourth performance of highly desired our economy, we're of want the Evolent pandemic
number ongoing Touching strong growth, three, we're of our operating discuss progress and margins; strong two, theme to let's against growth; Evolent's our pleased X capital today. optimal announce new expanding organic core Now one, organic first allocation. X operating partners objectives:
X off partner. XXXX growing with are our partners annual New partner Molina of partnerships, significant for to expansions our an with important clinical partners Century include to new X existing using X today's a partnerships the consider we new new with geographic target to performance pleased well of start strong in logos We're have announcements. to we're Healthcare, Health and X during added and suite. as announced XX As any as a partners versus new both reminder, XXXX operating
to our to an performance bring cardiology Molina signed suite agreement have We Nevada.
our addition, Washington Healthcare suite. have in Cardiology Performance to In Kentucky to elected Services our Molina State Technology from migrate suite and and
to we our in With value relationship guarantee feel improvements in in high-cost partner suite and million risk-bearing We plan expansion quality and Further, anticipate addition see payers Performance to compelling cost New services clinical the Ohio, to to $XX in reduction evidence our transfers deploying turn, Molina suite that the years. capturing partners believe the revenue our clinical the Evolent. than grow these expansions, suite, seeking and provide In the previously can whereby will margin and continue cost to announced we from savings for in proprietary a a offer the advanced proposition, scope partner opportunity the Performance performance with drive technology we create our from platform, responsibility Technology is of specialties. a our of to by we of providers using XXXX, We, to our contribute base. health intellectual Molina rate we and partner opportunity a within existing scaled more that Services medical conversion Century future X are capitation further who property. we with value
care have also extended model through we that this Partners primary pleased business. are our to suite Evolent Care We Performance
Care Health of Bright with Shield our across first care today, is January and XXXX, over care Beginning network support Blue Services operational administrative seek Partners our integrate to January are unnecessary North care market. Evolent's new improve Blue Premier Blue North and partnership XXXX, and quality we performance Effective members. costs. Evolent Advantage identify and look and Care payer/provider is began communities the for growth primary as our went health vendor leverage patient expand partnership, will estimated of with XXX,XXX multiyear with to Partners leading with model proven collaborating in Blue agreement Cross Rounding reduce delighted and announced and platform, suite Bright primary XX,XXX our Carolina. out they will Evolent health services space, programs Evolent independent the Blue management value-based previously Carolina announcement forward health payer national physicians a such, to patient-centered commercial engagement to payer integrated unique its is of the leverage the proprietary fourth to care Shield to live in improve plan As North initially X, Cross Medicare relationships a Carolina. work that whereby them to members. HealthCare. we an their We're we Bright plan disclosing of news Evolent managing
medium-term objective expansion. to pleased margin targets. of progress Moving our our towards second with our We're margin
will and fluctuations lower margin X year Given and larger years, which in products, revenue higher later see percentages. in from EBITDA rates continue have margins growth our suite to portion Performance mix high margins some year-to-year we of
be including expansion outlook, dollar growth confidence which adjusted reaching rates the of goals, us give believe on Our we targets. success with high conviction best our margin greater our medium-term our to indicator absolute EBITDA of revenue
theme to like is for discuss shareholder Evolent, which creation I'd optimal allocation. Finally, capital third our value of
our us enabling accelerate our Even to higher market scale further rapidly as our flow, and differentiated of solutions cash increasingly levels execution operating we generate our business, leadership.
second, deployment, capital and in partnerships. priority core third, is the to continued through X M&A through about innovation leadership market think R&D and capital-light through business; around core our we As our first, core; solutions: drive our strategic innovative in
Regarding the disciplined around our core, continue primary and to steady investment plan we R&D solutions. within
for to we're Services, transaction other scale within investments activity leveraging processing efficiently health Evolent Health our provider and and example, For intelligence partners. plan artificial more high-volume technology
a we our M&A end-of-life to By Century cost. XXXX Decisions quality Health, our better how M&A, end-of-life a enhances published our use manage total Vital expenditures. good into medical market Medicare is costs, deepens example XX acquisition overall to of CMS cardiology, impact and integrating Regarding capabilities Vital studies, Vital of of approximately extend during we of of to medical leadership. New spending. important those add Decisions last to Decisions and According especially the life within person's and oncology greatly XX% which the costs majority are represent ability direct and months
well is going Our is Vital integration on schedule. and
During XXXX, we'll continue strategic other to acquisition accretive opportunities. evaluate
and continue the Given continued particularly leadership platform high opportunities to we see to the market, interesting M&A. our deepen New broaden Century in demand position through market and
seek also with or minimal we to through R&D or partnerships capital. no use Third, M&A of innovate
that example, effectiveness This minimize further optimize the of we partnered effects. the are space. in within and oncology, For maximize evolving seeks relationship treatments efficacy, pharmacogenomic side risk to
care oncology with seeks expand Carson value-based addition, Valtruis In delivery hybrid partnering Welsh we're that new the model. a capacity organization backed to with
complementing environment to early Collectively, Evolent with identification These care. current ability deploying optimistic conclude, profitable innovate you we in long-term as primary our with without accelerate to remain pertains Partners, build we treatment partnerships, to care perspective them to solutions, significant both continue capital. like on to others R&D, and and public Finally, where M&A Evolent's to business the and give our us kidney Care and existing in growth. and have relationships the and regarding our want leadership private an stands partnered extend focused allowing our To market across focus care-centric I it support value-based organization enhance to our sectors.
As you improving while to quality. value-based there many of many unsustainable care's experiments care models going curve and know, bend health all attempting cost on, are
XXXX savings as shared level ensure XXXX for dramatic generated scores programs most the a Medicare the the CMS of total On XX%, between the increase sevenfold XXXX. CMS XXXX. in XXXX, importantly, public relationships side, value-based savings beneficiaries between quality Also Shared highest and with XXXX program. for reports were in initiation by you're since aware, XXX% Medicaid and of earned the average Program acceleration to The and Medicare are likely seeks Savings
not feedback chose Innovation's While Success, Center focus participate Medicare the decades called We're Pathways and support we to similar instead proven stakeholder time, with our Program direct Savings in programs and confident discussed, highly ahead. Medicare previously in Success in the over value reflect but also current to confident As there's model evolve various Medicaid surely more for broad opportunities the and the program. near-term on that contracting Shared we're to to formats Evolent for will model Pathways the bipartisan years
importantly, risk-based More models provider a see and the we also in private markets. value payer strong push to continue to
and down and their strong by numerous their demand to national see through up quality solutions. to drive efforts our evidenced providers payers engaging highlighting As provider continue networks, we costs risk-bearing for
Taken macro numbers on together, now our direction, quarter the private market trends of give come. for the give provide the I'll outlook. strong some these years John us impact to to confidence we'll ask have and this policy tailwinds detail also and that
